UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation

European journal of case reports in internal medicine, 2022-07, Vol.9 (7), p.003343-003343

2022

Volltextzugriff (PDF)

Real‐world experience of rIX‐FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy – Results from IDEAL Part B

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.1067-1070

2024

Volltextzugriff (PDF)

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Thrombosis and haemostasis, 2015-07, Vol.114 (1), p.35

2015

Volltextzugriff (PDF)

Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study

European journal of haematology, 2024-05, Vol.112 (5), p.765-775

2024

Volltextzugriff (PDF)

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

British journal of haematology, 2022-02, Vol.196 (4), p.871-883

2022

Volltextzugriff (PDF)

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes

Journal of thrombosis and haemostasis, 2022-01, Vol.20 (1), p.69-81

2022

Volltextzugriff (PDF)

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

European journal of haematology, 2022-08, Vol.109 (2), p.121-128

2022

Volltextzugriff (PDF)

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.937-945

2020

Volltextzugriff (PDF)

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.135-144

2023

Volltextzugriff (PDF)

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Patient preference and adherence, 2020-03, p.233

2020

Volltextzugriff (PDF)

Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.e575-e578

2021

Volltextzugriff (PDF)

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-09, Vol.24 (5), p.766-773

2018

Volltextzugriff (PDF)

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Blood transfusion = Trasfusione del sangue, 2020-03, Vol.18 (2), p.143-151

2020

Volltextzugriff (PDF)

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Patient preference and adherence, 2019-01, Vol.13, p.233-240

2019

Volltextzugriff (PDF)

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis

Blood transfusion = Trasfusione del sangue, 2018-07, Vol.16 (4), p.371-381

2018

Volltextzugriff (PDF)

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Patient preference and adherence, 2019-02, Vol.13, p.233

2019

Volltextzugriff (PDF)

Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-07, Vol.25 (4), p.656-667

2019

Volltextzugriff (PDF)

New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey

Blood transfusion = Trasfusione del sangue, 2020-01, Vol.18 (1), p.58-66

2020

Volltextzugriff (PDF)

Epidemiological data and treatment strategies in children with severe haemophilia in Italy

Annali dell'Istituto superiore di sanità, 2020-01, Vol.56 (4)

2020

Volltextzugriff (PDF)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.528-541

2019

Volltextzugriff (PDF)

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-07, Vol.20 (4), p.e243-e250

2014

Volltextzugriff (PDF)

Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

ClinicoEconomics and outcomes research, 2015-01, Vol.7 (default), p.17-25

2015

Volltextzugriff (PDF)

Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.444-453

2008

Volltextzugriff (PDF)

Evidence-based recommendations on the treatment of von Willebrand disease in Italy

Blood transfusion = Trasfusione del sangue, 2009-04, Vol.7 (2), p.117-126

2009

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation

Real‐world experience of rIX‐FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy – Results from IDEAL Part B

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis

Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A

Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project

New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey

Epidemiological data and treatment strategies in children with severe haemophilia in Italy

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis

Evidence-based recommendations on the treatment of von Willebrand disease in Italy

Suchergebnisse filtern